Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Cephalon Inc, Capitol Federal Financial, Corinthian Colleges Inc.

Guru Stocks at 52-Week Low: GENZ, APOL, CEPH, CFFN, COCO

Author's Avatar
Dec 07, 2009
Last week’s top five stocks that reached their 52-week lows were Genzyme Corp, Apollo Group Inc, Cephalon Inc, Capitol Federal Financial, and Corinthian Colleges Inc. According to GuruFocus updates, these Guru stocks have reached their 52-week lows.


Last week’s top two out of favor industries were the Banking and Media industries. 24 banks have reached their 52-week lows, while 29 have reached their 52-week highs, giving the industry a low/high ratio of 0.83. In the Media industry, 3 stocks have reached their 52-week lows, while 12 have reached their 52-week highs, giving the industry a low/high ratio of 0.25.


For full details about guru stocks at 52-week lows and more information, click here: http://www.gurufocus.com/52weeklow.php


Genzyme Corp. (GENZ, Financial) Reached the 52-Week Low of $49.98

The prices of Genzyme Corp. (GENZ) shares have declined to close to the 52-week low of $49.98, which is 34.2% off the 52-week high of $73.21. Genzyme Corp. is owned by 12 Gurus we are tracking. Among them, 4 have added to their positions during the past quarter. 5 reduced their positions.


Genzyme Corporation is a global biotechnology company dedicated to making a major positive impact on the lives of people with serious diseases. The company has a market cap of $13.51 billion; its shares were traded at around $49.98 with a P/E ratio of 17.6 and P/S ratio of 2.9. Genzyme Corp. had an annual average earning growth of 20.2% over the past 10 years. GuruFocus rated Genzyme Corp. the business predictability rank of 4-star.


Genzyme recently reported its third quarter results. The company announced that its third-quarter revenue was $1.06 billion, compared with $1.16 billion in the same period a year ago. Results reflect the impact of the temporary interruption in production of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) associated with the remediation of the company’s Allston manufacturing facility.


Carl Icahn bought 1,450,800 shares in the quarter that ended on 09/30/2009, which is 2.63% of the $3.13 billion portfolio of Icahn Capital Management LP. Jean-Marie Eveillard owns 458,264 shares as of 09/30/2009, an increase of 32586.4% from the previous quarter. This position accounts for 0.24% of the $10.76 billion portfolio of Arnhold & S. Bleichroeder Advisers, LLC.


Sell:: Chmn, President and CEO Henri A Termeer sold 200,000 shares of GENZ stock on 11/23/2009 at the average price of 50.47, the price of the stock has decreased by 0.97% since


Apollo Group Inc. (APOL, Financial) Reached the 52-Week Low of $54.76


The prices of Apollo Group Inc. (APOL) shares have declined to close to the 52-week low of $54.76, which is 39.6% off the 52-week high of $89.22. Apollo Group Inc. is owned by 9 Gurus we are tracking. Among them, 7 have added to their positions during the past quarter. 1 reduced their position.


Apollo Group, Inc. has been providing higher education to working adults for over 25 years. They operate through their subsidiaries, the University of Phoenix, Inc., the Institute for Professional Development, the College for Financial Planning Institutes Corporation, Western International University, Inc., and Apollo Learning Group, Inc. Apollo Group Inc. has a market cap of $8.45 billion; its shares were traded at around $54.76 with a P/E ratio of 13 and P/S ratio of 2.1. Apollo Group Inc. had an annual average earning growth of 29.1% over the past 10 years. GuruFocus rated Apollo Group Inc. the business predictability rank of 4-star.


Apollo Group recently reported its third quarter 2009 results. The company announced that its net revenue for the quarter was over $1 billion, up 26% compared to results as of the third quarter of 2008. Net income was $1.26 per share, compared to 85 cents per share in the third quarter of 2008. “We are pleased to report a record third quarter, driven largely by continuing increases in enrollments and improved student retention at University of Phoenix,” said Co-Chief Executive Officer of Apollo Group, Chas Edelstein. “When our students succeed academically, we succeed financially and, for the first time in a quarter, Apollo surpassed the $1 billion revenue mark.”


Ken Heebner bought 1,000,000 shares in the quarter that ended on 09/30/2009, which is 1.1% of the $6.72 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. John Rogers bought 102,060 shares in the quarter that ended on 09/30/2009, which is 0.17% of the $4.51 billion portfolio of ARIEL CAPITAL MANAGEMENT LLC. George Soros bought 4,500 shares in the quarter that ended on 09/30/2009, which is 0.01% of the $4.41 billion portfolio of Soros Fund Management LLC.


Buy:: Director Stephen Giusto bought 1,000 shares of APOL stock on 10/30/2009 at the average price of 58.19, the price of the stock has decreased by 5.89% since. However, other insiders have decreased their positions in the company.


Cephalon Inc. (CEPH, Financial) Reached the 52-Week Low of $55.38


The prices of Cephalon Inc. (CEPH) shares have declined to close to the 52-week low of $55.38, which is 33.6% off the 52-week high of $80.26. Cephalon Inc. is owned by 3 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 3 reduced their positions.


Cephalon is an international biopharmaceutical company focused on thediscovery, development and marketing of products to treat sleep disorders,neurological disorders, cancer and pain. In addition to an active research and development program, they market products in the United States and various countries in Europe. Cephalon Inc. has a market cap of $4.13 billion; its shares were traded at around $55.38 with a P/E ratio of 9.5 and P/S ratio of 2.1. Cephalon Inc. had an annual average earning growth of 10.1% over the past 5 years.


Cephalon Inc. recently reported its third quarter 2009 results. The company announced that its sales were $535.2 million, compared with $489.7 million a year ago, or up 9%. Income per share was $1.38. "The exceptional launch of NUVIGIL was the highlight of the quarter," said Frank Baldino, Jr., Ph.D., Chairman and CEO. "In addition, we have assembled the deepest and most diverse pipeline in our history with a variety of small molecules and biologics being studied for pain, oncology, and inflammatory diseases. We look forward to developing this diverse pipeline with the goal of creating important new medicines for patients."


Edward Owens owns 2,752,000 shares as of 09/30/2009, an increase of 37.46% from the previous quarter. This position accounts for 0.88% of the $18.2 billion portfolio of Vanguard Health Care Fund.


Sell:: Exec. VP, Chief Compliance Off Valli F. Baldassano sold 650 shares of CEPH stock on 09/21/2009 at the average price of 59.75, the price of the stock has decreased by 7.31% since


Capitol Federal Financial (CFFN, Financial) Reached the 52-Week Low of $29.33


The prices of Capitol Federal Financial (CFFN) shares have declined to close to the 52-week low of $29.33, which is 37.8% off the 52-week high of $45.67. Capitol Federal Financial is owned by 1 Gurus we are tracking.


Capitol Federal Financial is a federally chartered mid-tier holding company. Capitol Federal Savings Bank is the only operating subsidiary. Capitol Federal Financial has a market cap of $2.17 billion; its shares were traded at around $29.33 with a P/E ratio of 32.4 and P/S ratio of 5. The dividend yield of Capitol Federal Financial stocks is 6.9%. Capitol Federal Financial had an annual average earning growth of 33.8% over the past 5 years.


Capitol Federal Financial recently reported its fiscal year 2009 results. The company recognized net income of $66.3 million compared to net income of $51.0 million in fiscal year 2008. The $15.3 million increase in net income was primarily a result of a $40.5 million decrease in interest expense, partially offset by an $11.6 million increase in other expenses, a $9.7 million increase in income tax expense, and a $4.3 million increase in provision for loan loss. The net interest margin for fiscal year 2009 was 2.20% compared to 1.75% for fiscal year 2008. The 45 basis point increase in the net interest margin was primarily a result of a decrease in the weighted average rate on interest-bearing liabilities.


Corinthian Colleges Inc. (COCO, Financial) Reached the 52-Week Low of $13.9


The prices of Corinthian Colleges Inc. (COCO) shares have declined to close to the 52-week low of $13.9, which is 35.3% off the 52-week high of $21.47. Corinthian Colleges Inc. is owned by 3 Gurus we are tracking. Among them, 3 have added to their positions during the past quarter. 1 reduced their positions.


Corinthian Colleges, Inc. is one of the largest post-secondary education companies in North America, operating colleges in states in the U.S. and seven provinces in Canada. The company has a market cap of $1.21 billion; its shares were traded at around $13.9 with a P/E ratio of 12 and P/S ratio of 1. Corinthian Colleges Inc. had an annual average earning growth of 11% over the past 10 years.


Corinthian Colleges recently reported their third quarter results, and said that they exceeded the previous guidance. Net revenue was $346.4 million versus $279.9 million, up 23.8%. "Our strong third quarter results reflect the continued progress of our business initiatives as well as some favorable impact from the recession," said Jack Massimino, Corinthian's chairman and chief executive officer. "We have now reported increased start growth for twelve consecutive quarters, and the resulting rise in student population is leveraging fixed costs. In addition, increased marketing effectiveness and lower advertising costs are producing higher quality, less expensive leads. Given all of these factors, we achieved significant operating margin expansion in the quarter and raised earnings guidance for the balance of the fiscal year."


Arnold Van Den Berg bought 22,650 shares in the quarter that ended on 09/30/2009, which is 0.03% of the $1.49 billion portfolio of Century Management.


Buy:: Director Robert Lee bought 1,000 shares of COCO stock on 11/02/2009 at the average price of 16.26, the price of the stock has decreased by 14.51% since. However, other insiders have decreased their positions in the company.


Go here for the complete list of 52-week lows.